Haleon (HLN) Times Interest Earned (2021 - 2025)

Haleon's (HLN) quarterly Times Interest Earned came in at -$6.17 in Q4 2025, up 21.32% on a QoQ basis from -$7.84 in Q4 2023.

Haleon (HLN) Times Interest Earned (2021 - 2025) Analysis & Trends

Haleon (HLN) has 4 years of Times Interest Earned data on file, last reported at -$6.17 in Q4 2025.

Quarterly Times Interest Earned changed N/A year-over-year to -$6.17 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$9.66 (changed N/A YoY) and the FY2025 annual result came in at $7.09, up 23.49% from the prior year.
Times Interest Earned improved to -$6.17 in Q4 2025, from -$7.84 in the prior quarter.
In the past five years, Times Interest Earned ranged from a high of -$4.15 in Q2 2023 to a low of -$367.25 in Q4 2022.
A 4-year average of -$107.89 and a median of -$7.84 in 2023 frame the typical range for Times Interest Earned.
Annual changes were most pronounced in 2022 — Times Interest Earned sank 165.7% — and 2023, when it surged 97.86%.
Tracing HLN's Times Interest Earned over 4 years: stood at -$138.22 in 2021, then tumbled by 165.7% to -$367.25 in 2022, then surged by 97.86% to -$7.84 in 2023, then climbed by 21.32% to -$6.17 in 2025.
The last three Times Interest Earned figures came in at -$6.17 (Q4 2025), -$7.84 (Q4 2023), and -$4.15 (Q2 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-	-
2	Teva Pharmaceutical Industries	43.28 Bn	39.62 Bn	2.15 Bn	-
3	Zoetis	31.78 Bn	30.11 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.71 Bn	22.91 Bn	5.10 Bn	-3.15
5	United Therapeutics	22.25 Bn	19.59 Bn	683.80 Mn	114.07
6	Viatris	18.72 Bn	17.83 Bn	1.46 Bn	0.05
7	Neurocrine Biosciences	15.57 Bn	15.18 Bn	935.80 Mn	52.24
8	Elanco Animal Health	11.87 Bn	11.34 Bn	798.00 Mn	4.20
9	Dr Reddys Laboratories	10.14 Bn	9.97 Bn	-	-
10	Alkermes	8.14 Bn	7.48 Bn	397.90 Mn	0.71

Download Data